n Cardiovascular Journal of Africa - AstraZeneca Pharmaceuticals enables scientific innovation : industry news




Critically aware of the need for funding that will develop research capacity and contribute to academic advancement in South Africa, ethical pharmaceutical company, AstraZeneca Pharmaceuticals, has set up a not-for-profit trust for the disbursement of medical research funding. The company will award R1.5 million a year for three years for academic research; high-level, non-interventional studies including doctoral and postdoctoral work that will generate significant data currently not available.


Article metrics loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error